SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-053167
Filing Date
2021-04-21
Accepted
2021-04-21 16:15:47
Documents
1
Period of Report
2021-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2113676d2_form4.html 4  
1 FORM 4 tm2113676d2_form4.xml 4 4165
  Complete submission text file 0001104659-21-053167.txt   5521
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 NETWORK DRIVE BURLINGTON MA 34212
Business Address
Gayron Kenneth L (Reporting) CIK: 0001669103 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 21841715